Clinical Trials
2 trialsNCT02912559 2026-06-01
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair
National Cancer Institute (NCI)
Phase 3 Active not recruiting
NCT03236935 2026-04-09
Phase Ib of L-NMMA and Pembrolizumab
The Methodist Hospital Research Institute
Phase 1 Completed